|
Delayed
NSE India S.E.
07:42:42 13/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 2,304.40 INR | +0.63% |
|
+1.49% | +13.20% |
| 08-03 | Glenmark Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 03, 2026 | |
| 07-31 | India's Glenmark Pharma posts higher quarterly profit on strong demand | RE |
Chart: Technical Analysis
Stock exchange
NSE India S.E.
GLENMARK 2,304.40 ₹
+0.63%
351M
₹
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
NSE India S.E.
| GLENMARK | 2,304.40INR | +0.63% | 351M ₹ | |
Bombay S.E.
| GLENMARK | 2,300.70INR | +1.26% | 9.15M ₹ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bullish |
| Resistance | 2,305.1 | 2,417.9 | 2,406.3 |
| Spread/Res. | -0.06% | -4.72% | -4.26% |
| Spread/Supp. | +5.46% | +19.07% | +10.13% |
| Support | 2,184.6 | 1,934.8 | 2,091.8 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- GLENMARK Stock
- Charts Glenmark Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
